Document Detail


New medications for substance use disorders: challenges and opportunities.
MedLine Citation:
PMID:  22157859     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An increased understanding of the biological mechanisms underlying the process of addiction has led to unique molecular targets and strategies for pharmacotherapies against addiction. However, the successful translation of these discoveries will require: 1) a more active engagement of the pharmaceutical sector, 2) partnership with regulatory agencies to arrive at meaningful outcomes for medication approval and 3) a greater involvement of the healthcare system in the screening and treatment of substance use disorders.
Authors:
Nora D Volkow; Phil Skolnick
Related Documents :
21982719 - Monitoring drug safety with registries: useful components of postmarketing pharmacovigi...
22104059 - Toward "harder" medical humanities: moving beyond the "two cultures" dichotomy.
21765699 - The role of mathematical modeling in medical research: "research without patients?".
21574859 - A 'minimal core curriculum' for family medicine in undergraduate medical education: a e...
22197799 - Using incentives to reduce substance use and other health risk behaviors among people w...
22150919 - Brain death in islamic ethico-legal deliberation: challenges for applied islamic bioeth...
24280859 - How do you deliver a good obstetrician? outcome-based evaluation of medical education.
12670859 - A taste comparison of three different liquid steroid preparations: prednisone, predniso...
23391959 - Phenibut dependence.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology     Volume:  37     ISSN:  1740-634X     ISO Abbreviation:  Neuropsychopharmacology     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-14     Completed Date:  2012-08-21     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  8904907     Medline TA:  Neuropsychopharmacology     Country:  England    
Other Details:
Languages:  eng     Pagination:  290-2     Citation Subset:  IM    
Affiliation:
National Institute on Drug Abuse, Bethesda, MD 20892, USA. nvolkow@nida.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Design*
Forecasting
Humans
National Institutes of Health (U.S.) / trends*
Psychopharmacology / trends*
Substance-Related Disorders / drug therapy*
United States
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroscience networking: linking discovery to drugs.
Next Document:  Effect of Ankle Braces on Lower Extremity Joint Energetics in Single-Leg Landings.